Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 390-397

  Di Carlo, Emma ^a   Modesti, Andrea ^b   Coletti, Anna ^b   Colombo, Mario P ^c   Giovarelli, Mirella ^d   Forni, Guido ^d   Diodoro, Maria G ^a   Musiani, Piero ^a,e  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Ospedale SS Annunziata   (Italy)

Author keywords

Adhesion molecules; Chemokines; Cytokines; Endothelial cells; Gene therapy; IL4; IL5; Mouse mammary adenocarcinoma; Neutrophils; Tumour growth

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BREAST ADENOCARCINOMA; CANCER INHIBITION; CELL ACTIVATION; CELL INTERACTION; EOSINOPHIL; FEMALE; GENETIC TRANSDUCTION; IMMUNOCOMPETENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION;

ANIMALS; CELL ADHESION MOLECULES; ENDOTHELIUM; FEMALE; GENE THERAPY; INTERLEUKIN-4; INTERLEUKIN-5; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION;

EID: 0032412860     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<390::AID-PATH194>3.0.CO;2-Z     Document Type: Article

References (22)

1. Musiani P, Modesti A, Giovarelli M, et al. Cytokines, tumor-cell death and immunogenicity: a question of choice. Immunol Today 1997; 18: 32-36.
2. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548-551.
3. Pericle F, Giovarelli M, Colombo MP, et al. An efficient Th-2-type memory follows CD8+ lymphocyte driven and eosinophil mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 1994; 153: 5659-5673.
4. Tepper RI. The eosinophil-mediated antitumour activity of interleukin-4. J Allergy Clin Immunol 1994; 94: 1225-1231.
5. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989; 19: 701-705.
6. Nanni P, De Giovanni C, Lollini PL, Nicoletti G, Prodi G. TS/A: a new metastatizating cell line originated from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Med 1983; 1: 373-380.
7. Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153-159.
8. Krüger-Krasagakes S, Li W, Richter G, Diamantstein T, Blankenstein T. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. Eur J Immunol 1993; 23: 992-995.
9. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992; 148: 1086-1092.
10. Rollins BJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991; 138: 1315-1319.
11. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591-2599.
12. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP Characterisation of human basophil response to cytokines, growth factors, and histamine releasins factors of the intercrine/chemokine family. J Immunol 1993; 150: 1932-1943.
13. Mantovani A. Tumour-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 1994; 71: 5-16.
14. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-623.
15. Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74: 165-172.
16. Platzer C, Richter G, Oberla K, Hock H, Diamantstein T, Blankenstein T. Interleukin-4-mediated tumour suppression in nude mice involves interferon-γ. Eur J Immunol 1992; 22: 1729-1733.
17. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91: 3652-3656.
18. Blanchard KD, Djeu JY, Klein TW, Friedman H, Stewart WE II. Interferon-γ induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol 1986; 136: 963-969.
19. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990; 172: 1425-1431.
20. Borish L, Rosenbaum R, Albury L, Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol 1989; 121: 280-289.
21. Westlin WF, Gimbrone MA Jr. Neutrophil-mediated damage to human vascular endothelium. Am J Pathol 1993; 142: 117-128.
22. Brozna JP. Shwartzman reaction. Semin Thromb Hemost 1990; 16: 326-332.